MAPK3 and CX3CL1 were strongly positive; NFE2L2, HSP90AB1, and SUPT20H were moderately positive; and FKBP1B, BIRC5, NPC1, IKBKE, BID, and PTEN were weakly positive in glioma tissue relative to their expression levels in normal tissue (Supplementary Figures S1A–K). The gene discussed is BID; the disease is central nervous system cancer.